Drug General Information
Drug ID	D07DAP
Former ID	DNC013969
Drug Name	4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529682]
Structure		Download 2D MOL 3D MOL
Formula	C14H14O4
Canonical SMILES	C1=CC(=C(C=C1O)O)CCC2=C(C=C(C=C2)O)O
InChI	1S/C14H14O4/c15-11-5-3-9(13(17)7-11)1-2-10-4-6-12(16)8-14(10)18/h3-8,15-18H,1-2H2
InChIKey	WKIFTWPZTZUMRN-UHFFFAOYSA-N
PubChem Compound ID	24849532
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[529682]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 529682	Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4. Epub 2008 Aug 22.Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton.
Ref 529682	Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4. Epub 2008 Aug 22.Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.